Norris Medicines Limited (BOM:524414)
13.56
+0.04 (0.30%)
At close: Jun 17, 2026
Norris Medicines Market Cap
Norris Medicines has a market cap or net worth of 135.01 million as of June 18, 2026. Its market cap has decreased by -35.68% in one year.
Market Cap
135.01M
Enterprise Value
350.15M
Revenue
81.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.56
Market Cap Chart
Since December 3, 2001, Norris Medicines's market cap has increased from 34.30M to 135.01M, an increase of 293.61%. That is a compound annual growth rate of 5.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 135.61M | -14.98% |
| Dec 31, 2025 | 159.51M | -8.07% |
| Dec 31, 2024 | 173.51M | 27.48% |
| Dec 29, 2023 | 136.11M | -1.95% |
| Dec 30, 2022 | 138.81M | 29.72% |
| Dec 31, 2021 | 107.01M | 72.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hamps Bio | 225.21M |
| Rekvina Laboratories | 221.35M |
| Cian Healthcare | 206.50M |
| Add-Shop E-Retail | 201.87M |
| Desh Rakshak Aushdhalaya | 199.44M |
| Zenith Healthcare | 167.67M |
| Colinz Laboratories | 146.74M |
| Ortin Global | 138.40M |